111248-89-6

Basic information

• Product Name: 1,3-DIHYDRO-2,1-BENZISOTHIAZOLE 2,2-DIOXIDE
• Synonyms: 1,3-DIHYDRO-2,1-BENZISOTHIAZOLE 2,2-DIOXIDE;1,3-dihydrobenzo[c]isothiazole 2,2-dioxide;2,1-Benzisothiazole, 1,3-dihydro-, 2,2-dioxide;1,3-dihydro-2,1-benzothiazole 2,2-dioxide
• CAS NO: 111248-89-6
• Molecular Formula: C₇H₇NO₂S
• Molecular Weight: 169
• Mol File: 111248-89-6.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 311.3±45.0 °C(Predicted)
• Appearance: /
• Density: 1.396±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 8.89±0.20(Predicted)
• CAS DataBase Reference: 1,3-DIHYDRO-2,1-BENZISOTHIAZOLE 2,2-DIOXIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-DIHYDRO-2,1-BENZISOTHIAZOLE 2,2-DIOXIDE(111248-89-6)
• EPA Substance Registry System: 1,3-DIHYDRO-2,1-BENZISOTHIAZOLE 2,2-DIOXIDE(111248-89-6)

Safety Data

• Hazardous Substances Data: 111248-89-6(Hazardous Substances Data)

Usage

General Description

1,3-Dihydro-2,1-benzisothiazole 2,2-dioxide is a chemical compound with the molecular formula C8H7NO2S. It is a heterocyclic organic compound that contains a benzene ring fused to an isothiazole ring, as well as a dioxide functional group. 1,3-DIHYDRO-2,1-BENZISOTHIAZOLE 2,2-DIOXIDE is often used as a building block in the synthesis of various pharmaceuticals and agrochemicals. It has potential applications in the treatment of cardiovascular diseases, cancer, and neurological disorders due to its ability to modulate ion channels and neurotransmitter release. Additionally, it has been studied for its potential use as a flame retardant due to its high thermal stability and low toxicity.

Upstream product

• 89665-79-2 (2-chlorophenyl)-methanesulfonamide 
• 77421-13-7 (2-chlorobenzyl)sulfonyl chloride 
• 24974-75-2 2-nitrobenzylsulfonyl chloride 
• 41345-06-6 sodium (2-nitrophenyl)methanesulfonate 
• 3958-60-9 2-nitrophenylmethyl bromide 
• 6961-82-6 2-chlorobenzenesulfonamide 
• 113283-03-7 2-bromo-α-toluenesulfonamide 
• 111249-29-7 2-aminobenzylsulfonic acid sodium salt 
• 20474-37-7 benzylsulfonyl azide 

Downstream Products

• 1455471-75-6 1-benzyl-5-bromo-1,3-dihydrobenzo[c]isothiazol-2,2-dioxide 
• 1455471-76-7 tert-butyl 2-(1-benzyl-2,2-dioxido-1,3-dihydrobenzo[c]isothiazol-5-yl)acetate 
• 111249-19-5 (4-Chloro-phenyl)-(7-nitro-2,2-dioxo-2,3-dihydro-2λ⁶-benzo[c]isothiazol-1-yl)-methanone 
• 111249-18-4 (4-Chloro-phenyl)-(5-nitro-2,2-dioxo-2,3-dihydro-2λ⁶-benzo[c]isothiazol-1-yl)-methanone 
• 111249-17-3 (5-Bromo-2,2-dioxo-2,3-dihydro-2λ⁶-benzo[c]isothiazol-1-yl)-(4-chloro-phenyl)-methanone 
• 111249-15-1 (5-Chloro-2,2-dioxo-2,3-dihydro-2λ⁶-benzo[c]isothiazol-1-yl)-(4-chloro-phenyl)-methanone 
• 111248-94-3 1,3-dihydro-5-nitro-2,1-benzoisothiazole 2,2-dioxide 
• 24827-66-5 1-methyl-1,3-dihydrobenzo[c]isothiazole-2,2-dioxide 
• 111249-21-9 1-(Toluene-4-sulfonyl)-1,3-dihydro-benzo[c]isothiazole 2,2-dioxide 
• 111249-13-9 1-(4-chlorobenzoyl)-1,3-dihydro-2,1-benzisothiazole 2,2-dioxide 
• 111249-11-7 (2,2-Dioxo-2,3-dihydro-2λ⁶-benzo[c]isothiazol-1-yl)-phenyl-methanone 
• 111248-95-4 1,3-dihydro-7-nitro-2,1-benzisothiazole 2,2-dioxide 
• 111248-96-5 1,3-dihydro-5,7-dinitro-2,1-benzisothiazole 2,2-dioxide 
• 111249-12-8 (2-Chloro-phenyl)-(2,2-dioxo-2,3-dihydro-2λ⁶-benzo[c]isothiazol-1-yl)-methanone 

Relevant articles and documents

NOVEL NAPHTHYRIDINES AND ISOQUINOLINES AND THEIR USE AS CDK8/19 INHIBITORS

The present invention relates to naphthyridine and isoquinoline compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of CDK8/19, and for the treatment of CDK8/19-related disorders.

PYRIDYL PIPERIDINES

The invention provides novel substituted pyridyl piperidine compounds according to Formula (I) which are Wnt pathway inhibitors, their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.

SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID RECEPTOR (KOR) AGONISTS

The present invention relates to a series of substituted compounds having the general formula (I), including their ste reoisomers and/or their pharmaceutically acceptable salts, wherein R1, R2, R3. R4, R5, and R6 are as defined herein. This invention also relates to methods of making these compounds including intermediates. The compounds of this invention are effective at the kappa (κ) opioid receptor (KOR) site. Therefore, the compounds of this invention are useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of central nervous system disorders (CNS), including but not limited to acute and chronic pain, and associated disorders, particularly functioning peripherally at the CNS.